Table 3.
Sample ID | Treatment | Relevant indicators | Growth | Intellectual development | ||
---|---|---|---|---|---|---|
Low-MET diet | Drugs | MET (min~max) | HCY (min~max) | |||
S1 | N | N | 94.26–184.67 | 3.45–10.76 | Normal | Normal |
S4 | Y | N | 220.59–393.93 | 6.30–22.66 | Normal | Normal |
S5 | Y | N | 296.99–703.22 | 4.73–12.56 | Normal | Normal |
S6 | N | N | 49.05–149.25 | / | Normal | Normal |
S7 | N | N | 38.92–192.51 | 11.0 | Normal | Normal |
S8 | N | N | 47.34–199.84 | 3.35–12.45 | Normal | Normal |
S9 | Y | N | 245.6–423.8 | 22.1–36.6 | Normal | Normal |
S10 | Y | Y | 729.19–1105.17* | 41.7* | Normal | Neurological manifestations with developmental lag |
“/” represents lack of clinical information.
HCY = homocysteine, MET = methionine, N = none, Y = yes.
Pretransplant outcome.